The company expects that this development could improve the strength of its application to the FDA for new drug approval
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
The company reported lifetime high EBIDTA of Rs. 250 crores
The company has reported total income of Rs. 3276.35 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
